Eli Lilly & Co.
LLY
NYSE
IPO1970
about LLY
Eli Lilly is a global pharmaceutical company that discovers, develops, manufactures, and sells a wide range of human healthcare products, with a strong focus on therapeutic areas like diabetes, obesity, immunology, oncology, and neuroscience.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $990.00 | $993.56 | $965.60 | $899.9B | 2.51M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$6.22 | 58.90 | 50.02 | 41.09% | 31.72% | 0.71% |
